Aegerion Pharmaceuticals Inc.

Aegerion Pharmaceuticals Inc.

Aegerion Pharmaceuticals Inc.

Overview
Date Founded

2005

Headquarters

1 Main Street,Suite 800,Cambridge, MA 02142

Type of Company

Private

Employees (Worldwide)

318

Industries

Pharmaceuticals
Hospitals & Patient Services
Biotechnology

Company Description

Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer and William H. Lewis in 2005 and is headquartered in Cambridge, MA.

Executives & Employees

President & Director

Chief Commercial Officer

Director, Investor & Corporate Communications

Senior Vice President & Global Chief Compliance Officer

Senior Vice President, Human Resources

Chief Scientific Officer

Executive Vice President & Head-Research

Executive Marketing Director

President, Amv Advisors

Board of Directors

President & Director at Aegerion Pharmaceuticals Inc.

Paths to Aegerion Pharmaceuticals Inc.
Potential Connections via
Relationship Science
You
Aegerion Pharmaceuticals Inc.
Recent Transactions
Details Hidden

Amryt Pharma PLC purchases Aegerion Pharmaceuticals Inc. from Novelion Therapeutics, Inc.

Details Hidden

QLT, Inc. purchases Aegerion Pharmaceuticals Inc. resulting in a new company Novelion Therapeutics, Inc.

Details Hidden

Aegerion Pharmaceuticals Inc. issued Common Stock

Transaction Advisors
Underwriter

Advised onAegerion Pharmaceuticals Inc. issued Common Stock

Underwriter

Advised onAegerion Pharmaceuticals Inc. issued Common Stock

Underwriter

Advised onAegerion Pharmaceuticals Inc. issued Common Stock

Head, Healthcare Investment Banking

Advised onAegerion Pharmaceuticals Inc. issued Common Stock

Legal Advisor

Advised onAegerion Pharmaceuticals Inc. issued . USD Common Stock

Legal Advisor

Advised onAegerion Pharmaceuticals Inc. issued Common Stock

Advisors & Consultants
Advisor

President & Chief Financial Officer at Chiasma, Inc.

Real Estate Agent

Vice Chairman, New England Area at CBRE Group, Inc.

Clients

Shionogi & Co., Ltd. engages in the research, development, supply, manufacture, and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.

Key Stats and Financials As of
Market Capitalization
$50.8M
Total Enterprise Value
Earnings Per Share
Investors
Details Hidden

Index is an active manager which focuses young information technology and life sciences companies in Europe, Israel and the US, which have the potential to become global players in their market. The firm typically co-invests with local venture capitalists outside Europe.Index invests USD 3 to 20 million, with the possibility of investing smaller amounts in seed rounds, such as USD 300 to 500 thousand. They acquire minority stakes (20% on average) and are active board members. Their initial investment focus is on series A and B rounds and they also participate in follow-up investments at later stages for companies that successfully execute their business plans.Index generally invests in six to ten new investments a year, holds investments for three to five years and seeks exits through IPOs and trade sales.

Details Hidden

Alta Partners Management Corp. specializes in investments in healthcare venture capital companies. The firm looks for Technology enabled solutions and services that improve delivery and quality of care with Strong entrepreneurs

Details Hidden

Advent International was founded in 1984 and is one of the largest and most experienced global private equity firms. With offices on four continents, they have established a globally integrated team of over 180 investment professionals, focused on buyouts and growth equity investments in five core sectors. Since initiating their private equity strategy in 1989, they have invested $33 billion in 325 transactions across 40 countries, and as of December 31, 2016, managed $41 billion in assets.

Suppliers
University of Pennsylvania Investment Services & Portfolio Management | PHILADELPHIA, PA

The University of Pennsylvania (commonly referred to as Penn or UPenn) is a private, Ivy League university, located in Philadelphia, Pennsylvania, United States. Penn considers itself the fourth-oldest institution of higher education in the United States, as well as the first university in the United States with both undergraduate and graduate studies.

Amgen, Inc. Hospitals & Patient Services | Thousand Oaks, CA

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Competitors
Regeneron Pharmaceuticals, Inc. Pharmaceuticals - Tarrytown, New York

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Amgen, Inc. Biotechnology - Thousand Oaks, CA

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Aegerion Pharmaceuticals Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Aegerion Pharmaceuticals Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Aegerion Pharmaceuticals Inc..